Surgery Partners’ (SGRY) “Buy” Rating Reiterated at TD Cowen

Surgery Partners (NASDAQ:SGRY)‘s stock had its “buy” rating restated by research analysts at TD Cowen in a note issued to investors on Friday, September 18th, Benzinga reports. They currently have a $19.00 price target on the stock. TD Cowen’s target price points to a potential upside of 31.94% from the stock’s previous close.

A number of other equities analysts have also recently issued reports on the company. Zacks Research cut Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. Benchmark reiterated a “buy” rating on shares of Surgery Partners in a report on Tuesday, August 11th. Raymond James Financial set a $18.00 target price on Surgery Partners in a report on Tuesday, August 11th. JPMorgan Chase & Co. increased their target price on Surgery Partners from $14.00 to $15.00 and gave the stock a “neutral” rating in a report on Monday, September 14th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $18.00 target price on shares of Surgery Partners in a report on Tuesday, August 11th. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $19.00.

Surgery Partners Trading Up 1.4%

Shares of SGRY traded up $0.20 during trading hours on Friday, reaching $14.40. The stock had a trading volume of 1,762,754 shares, compared to its average volume of 1,744,611. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. Surgery Partners has a 52 week low of $11.41 and a 52 week high of $23.44. The firm has a 50-day moving average of $14.71 and a 200 day moving average of $14.26. The company has a market cap of $1.89 billion, a P/E ratio of -20.57, a P/E/G ratio of 4.89 and a beta of 1.92.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.04. The firm had revenue of $848.90 million during the quarter, compared to analysts’ expectations of $830.03 million. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%.The company’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.17 EPS. On average, sell-side analysts expect that Surgery Partners will post 0.25 earnings per share for the current fiscal year.

Insider Activity at Surgery Partners

In other Surgery Partners news, Director Teresa DeLuca acquired 10,000 shares of Surgery Partners stock in a transaction dated Tuesday, August 18th. The stock was bought at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the purchase, the director directly owned 66,843 shares in the company, valued at approximately $959,197.05. This represents a 17.59% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Surgery Partners

A number of large investors have recently modified their holdings of the business. Jupiter Topco LLC acquired a new position in shares of Surgery Partners during the 2nd quarter worth about $233,220,000. Pentwater Capital Management LP acquired a new position in shares of Surgery Partners during the 2nd quarter worth about $195,384,000. BlackRock Inc. acquired a new position in shares of Surgery Partners during the 2nd quarter worth about $104,857,000. Dimensional Fund Advisors LP boosted its stake in shares of Surgery Partners by 7.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,296,411 shares of the company’s stock worth $63,131,000 after buying an additional 389,831 shares during the last quarter. Finally, Hsbc Holdings PLC acquired a new position in shares of Surgery Partners during the 2nd quarter worth about $48,912,000.

About Surgery Partners

Surgery Partners, Inc (NASDAQ: SGRY) is a healthcare services company that owns and operates a network of ambulatory surgery centers and surgical hospitals in the United States. The company works with physicians and health systems to provide outpatient and same-day surgical care in settings outside traditional hospital facilities.

Its services cover a range of specialties, including orthopedics, pain management, gastroenterology, ophthalmology, gynecology, urology and other procedural areas.